Third Harmonic Bio, Inc.
THRD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $37 | $24 | $24 | $16 |
| G&A Expenses | $22 | $20 | $13 | $3 |
| SG&A Expenses | $22 | $20 | $13 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $59 | $44 | $38 | $19 |
| Operating Income | $59 | -$44 | -$38 | -$19 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$13 | $13 | $3 | -$11 |
| Pre-Tax Income | $45 | -$31 | -$35 | -$30 |
| Tax Expense | $0 | $0 | $3 | $0 |
| Net Income | $45 | -$31 | -$38 | -$30 |
| % Margin | – | – | – | – |
| EPS | 1.09 | -0.78 | -0.89 | -0.77 |
| % Growth | 239.7% | 12.4% | -15.6% | – |
| EPS Diluted | 1.09 | -0.78 | -0.89 | -0.77 |
| Weighted Avg Shares Out | 42 | 40 | 39 | 39 |
| Weighted Avg Shares Out Dil | 42 | 40 | 39 | 39 |
| Supplemental Information | – | – | – | – |
| Interest Income | $13 | $13 | $0 | $0 |
| Interest Expense | $0 | $0 | $3 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $19 |
| EBITDA | -$45 | -$31 | -$35 | -$11 |
| % Margin | – | – | – | – |